The Competition Commission of India rejected an official complaint lodged against the Health & Family Welfare Department of Odisha, stating the regulator did not find sufficient evidence to open a case. Various parties including medical shop Oracle Drugs issued the complaint against the health department alleging anticompetitive behavior for imposed discounts on healthcare shops at levels higher than initially agreed upon. The department, whose main objective is to provide affordable healthcare, was cleared of any charges as the CCI found the discounts not to be anticompetitive.
Featured News
Meta Halts Commercial Terms Rollout After Publishers Raise Concerns in EU, UK
Oct 28, 2026 by
CPI
Nvidia’s $12.9 Billion Hugging Face Deal Draws Justice Department Questions
Oct 28, 2026 by
CPI
Rolls-Royce’s UltraFan Wins £2.5 Billion UK Framework Deal
Oct 28, 2026 by
CPI
Taiwan Blocks Grab’s $600 Million Foodpanda Deal, Citing Uber Ties
Oct 28, 2026 by
CPI
South Korea Expands Food Price-Fixing Probe to Four Major Instant Noodle Makers
Oct 28, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Exclusive Dealing
Oct 25, 2026 by
CPI
Exclusive Dealing Without Exclusivity: Screening Contracts, Loyalty Rebates, and the Limits of Antitrust Tests
Oct 25, 2026 by
David Martimort & Jérôme Pouyet
When Competition for Exclusivity Raises Prices: Rebates, Pricing Rules, and the Insulin Puzzle
Oct 25, 2026 by
Daniel P. O’Brien & Greg Shaffer
Why Leaving the Door Open Can Be (Much) Worse Than Closing It: Share-Based Requirements, Buyer-Specific Costs, and Foreclosure
Oct 25, 2026 by
Zhijun Chen & Greg Shaffer
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI